Position in NVCT
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$577,335
+$557,268 QoQ
Shares Held
31,394
+1109.3% QoQ
Ownership
0.096%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#29
of 82 holders
Holding Since
Jun 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVCT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026SIMPLEX TRADING, LLC holds $83,352,766 across 183 Biotechnology names. NVCT ranks #31 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRNA |
Moderna, Inc.
|
154,558 | $10,823,696 | |
| 2 | QURE |
uniQure N.V.
|
110,219 | $5,076,687 | |
| 3 | ERAS |
Erasca, Inc.
|
276,988 | $5,074,420 | |
| 4 | AXSM |
Axsome Therapeutics, Inc.
|
19,643 | $4,808,017 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
55,535 | $4,136,246 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
11,567 | $3,482,014 | |
| 7 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
29,002 | $2,363,953 | |
| 8 | SLS |
SELLAS Life Sciences Group, Inc.
|
154,099 | $2,274,501 |
All Filings in NVCT
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $577,335 | 31,394 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $20,067 | 2,596 | Shares | Sole | 2026-05-14 | |
| 2025-06-30 | $15,791 | 2,114 | Shares | Sole | 2025-08-05 | |
| No filing history on record for this holder in this stock. | ||||||